Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Adare Pharmaceuticals, Inc. 401(K) Plan is a benefit plan reported by Adare Pharmaceuticals, Inc. under EIN 31-0988732 and plan number 003. The latest loaded filing year is 2023. The filing reports 324 participants and $57,752,901 in end-of-year plan assets, where available in the loaded dataset.
Reported financial statement (2023 · Schedule H)
Net assets
- Total assets (EOY)
- $57,752,901
- Total liabilities (EOY)
- $5,003
- Net assets (EOY)
- $57,747,898
- Net assets (BOY)
- $33,236,475
Income & contributions
- Employer contributions
- $1,942,784
- Participant contributions
- $3,989,335
- Total contributions
- $6,882,509
- Total income / additions
- $15,383,368
Expenses & distributions
- Benefits paid
- $3,594,774
- Administrative expenses
- $107,326
- Total expenses
- $3,702,100
- Net increase / (decrease)
- $11,681,268